XBiotech Inc. (NASDAQ: XBIT) reports a new 52-week high and has $11.01 target or 3.00% above today’s $10.69 share price. Thorold News reports on the stock based on its recent success in Phase 2 with its Hidradenitis Suppurativa investigative compound—bermekimab.

Source: whatsonthorold.com

Pin It on Pinterest